Researchers introduced TxBench-PP, a benchmark for evaluating AI agents in small-molecule preclinical pharmacology. It provides a standardized way to assess AI performance in drug discovery, focusing on realistic program decisions. The benchmark aims to facilitate trusted evaluation and deployment of AI agents in this field. You can use TxBench-PP to compare AI models and improve their performance in drug discovery.